Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
0.8249
-0.0151 (-1.80%)
At close: Jul 20, 2026, 4:00 PM EDT
0.8090
-0.0159 (-1.93%)
After-hours: Jul 20, 2026, 7:57 PM EDT
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $35.5 million as of July 20, 2026. Its market cap has increased by 15.05% in one year.
Market Cap
35.50M
Enterprise Value
33.57M
1-Year Change
15.05%
Ranking
Category
Stock Price
$0.82
ChartMarket Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $35.50M, an increase of 1,897.01%. That is a compound annual growth rate of 122.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 35.50M | -39.74% |
| Dec 31, 2025 | 58.91M | 35.70% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
| Oct 19, 2022 | 1.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NanoViricides | 39.87M |
| RenovoRx | 39.02M |
| Veru Inc. | 38.20M |
| Nutriband | 37.81M |
| Lantern Pharma | 36.62M |
| Genenta Science | 36.57M |
| Aligos Therapeutics | 35.52M |
| Actuate Therapeutics | 34.45M |